122 related articles for article (PubMed ID: 36350754)
1. Long-lasting otic medications may be a rare cause of neurogenic keratoconjunctivitis sicca in dogs.
Bercovitz GR; Gaerig AM; Conway ED; Huey JA; Telle MR; Stavinohova R; Cherubini GB; Capasso A; Myrna KE
J Am Vet Med Assoc; 2022 Nov; 261(1):97-103. PubMed ID: 36350754
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical florfenicol, terbinafine and mometasone furoate ear drops on adrenocortical function in healthy small breed dogs with bilateral otitis externa.
Hoppers S; Drake E; Frank LA; Sun X
Vet Dermatol; 2022 Jun; 33(3):192-e54. PubMed ID: 34904763
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, single-blinded, multicenter evaluation of the efficacy and safety of a once weekly two dose otic gel containing florfenicol, terbinafine and betamethasone administered for the treatment of canine otitis externa.
King SB; Doucette KP; Seewald W; Forster SL
BMC Vet Res; 2018 Oct; 14(1):307. PubMed ID: 30305092
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of the efficacy and safety of a terbinafine, florfenicol and betamethasone topical ear formulation in dogs for the treatment of bacterial and/or fungal otitis externa.
Forster SL; Real T; Doucette KP; King SB
BMC Vet Res; 2018 Aug; 14(1):262. PubMed ID: 30170597
[TBL] [Abstract][Full Text] [Related]
5. Clinical safety and efficacy of a single-dose gentamicin, posaconazole and mometasone furoate otic suspension for treatment of canine otitis externa.
Heuer L; Wilhelm C; Roy O; Löhlein W; Wolf O; Zschiesche E
Vet Rec; 2024 May; 194(9):e3955. PubMed ID: 38462781
[TBL] [Abstract][Full Text] [Related]
6. Impact of a terbinafine-florfenicol-betamethasone acetate otic gel on the quality of life of dogs with acute otitis externa and their owners.
Noli C; Sartori R; Cena T
Vet Dermatol; 2017 Aug; 28(4):386-e90. PubMed ID: 28295766
[TBL] [Abstract][Full Text] [Related]
7. Neurogenic keratoconjunctivitis sicca in 34 dogs: A case series.
Galley AP; Beltran E; Tetas Pont R
Vet Ophthalmol; 2022 Mar; 25(2):140-152. PubMed ID: 34870366
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
9. Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
Morgan RV; Abrams KL
J Am Vet Med Assoc; 1991 Oct; 199(8):1043-6. PubMed ID: 1748607
[TBL] [Abstract][Full Text] [Related]
10. Effect of once daily topical 0.3% naltrexone on tear parameters and corneal sensitivity in dogs with uncontrolled keratoconjunctivitis sicca: a double-masked randomized placebo-controlled clinical trial.
Chen T; Powell CC
Vet Ophthalmol; 2015 Nov; 18(6):497-501. PubMed ID: 25675975
[TBL] [Abstract][Full Text] [Related]
11. Impact of synthetic canine cerumen on in vitro penetration of auricular skin of dogs by florfenicol, terbinafine, and betamethasone acetate.
Ehling S; Baynes RE; Bäumer W
Am J Vet Res; 2018 Mar; 79(3):333-341. PubMed ID: 29466046
[TBL] [Abstract][Full Text] [Related]
12. Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye.
Carrington S; Bedford PG; Guillon JP; Carlile JL; Woodward EG
Vet Rec; 1988 Sep; 123(13):329-35. PubMed ID: 3195015
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tear film osmolarity using the TearLab
Sebbag L; Park SA; Kass PH; Maggs DJ; Attar M; Murphy CJ
Vet Ophthalmol; 2017 Jul; 20(4):357-364. PubMed ID: 27761982
[TBL] [Abstract][Full Text] [Related]
14. Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002).
Klauss G; Giuliano EA; Moore CP; Stuhr CM; Martin SL; Tyler JW; Fitzgerald KE; Crawford DA
J Am Vet Med Assoc; 2007 Feb; 230(4):541-7. PubMed ID: 17302553
[TBL] [Abstract][Full Text] [Related]
15. Canine neurogenic Keratoconjunctivitis sicca: 11 cases (2006-2010).
Matheis FL; Walser-Reinhardt L; Spiess BM
Vet Ophthalmol; 2012 Jul; 15(4):288-90. PubMed ID: 22051024
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.
Coassin M; Lambiase A; Costa N; De Gregorio A; Sgrulletta R; Sacchetti M; Aloe L; Bonini S
Graefes Arch Clin Exp Ophthalmol; 2005 Feb; 243(2):151-5. PubMed ID: 15650854
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
18. Reduced tear production in three canine endocrinopathies.
Williams DL; Pierce V; Mellor P; Heath MF
J Small Anim Pract; 2007 May; 48(5):252-6. PubMed ID: 17425694
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
[TBL] [Abstract][Full Text] [Related]
20. Scanning electron microscopy of experimental keratoconjunctivitis sicca in dogs: cornea and bulbar conjunctiva.
Kern TJ; Erb HN; Schaedler JM; Dougherty EP
Vet Pathol; 1988 Nov; 25(6):468-74. PubMed ID: 3212890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
